Next Article in Journal
Development of Irinotecan Liposome Armed with Dual-Target Anti-Epidermal Growth Factor Receptor and Anti-Fibroblast Activation Protein-Specific Antibody for Pancreatic Cancer Treatment
Next Article in Special Issue
Navitoclax Enhances the Therapeutic Effects of PLK1 Targeting on Lung Cancer Cells in 2D and 3D Culture Systems
Previous Article in Journal
Cu2+-Chelating Mesoporous Silica Nanoparticles for Synergistic Chemotherapy/Chemodynamic Therapy
Previous Article in Special Issue
Evaluation of 3-Borono-l-Phenylalanine as a Water-Soluble Boron Neutron Capture Therapy Agent
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(6), 1201; https://doi.org/10.3390/pharmaceutics14061201
Action Date Notes Link
article xml file uploaded 4 June 2022 13:28 CEST Original file -
article xml uploaded. 4 June 2022 13:28 CEST Update https://www.mdpi.com/1999-4923/14/6/1201/xml
article pdf uploaded. 4 June 2022 13:28 CEST Version of Record https://www.mdpi.com/1999-4923/14/6/1201/pdf
article html file updated 4 June 2022 13:30 CEST Original file -
article html file updated 3 August 2022 03:34 CEST Update https://www.mdpi.com/1999-4923/14/6/1201/html
Back to TopTop